A Randomized Prospective Multicenter Phase III Trial Comparing Standard GvHD Prophylaxis with Cyclosporine and Methotrexate with Additional Pretransplant ATG Fresenius (ATG-F) in Allogeneic Stem Cell Transplantation from Matched Unrelated Donors
Year: 2008
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Blood
Authors: Jürgen Finke, Wolfgang Andreas Bethge, Claudia Schmoor, Hellmut Ottinger, Matthias Stelljes, Axel Zander, Liisa Volin, Dominik Heim, Rainer Schwerdtfeger, Karin Kolbe, Jiri Mayer, Johan Maertens, Werner Linkesch, Ernst Holler, Vladimir Koza, Martin Bornhaeuser, Hermann Einsele, Hans-Jochem Kolb, Hartmut Bertz, Matthias Egger, Olga Grichina, Gerard Socie
Institutions: University Medical Center Freiburg, University of Tübingen, Essen University Hospital, University of Münster, Universität Hamburg, University Medical Center Hamburg-Eppendorf, Helsinki University Hospital, University Hospital of Basel, Deutsche Klinik für Diagnostik, Johannes Gutenberg University Mainz, Masaryk University, University Hospital Brno, Universitair Ziekenhuis Leuven, Medical University of Graz, University Hospital Regensburg, University of Regensburg, Charles University, University Hospital Plzen, University Hospital Carl Gustav Carus, Universitätsklinikum Würzburg, LMU Klinikum, Ludwig-Maximilians-Universität München
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2580240004